Factors affecting snakebite mortality in north-eastern Nigeria-Reference-Cited by-同舟云学术

Factors affecting snakebite mortality in north-eastern Nigeria

Published:2011-03 Issue:1 Volume:3 Page:50-55
ISSN:1876-3413
Container-title:International Health
language:en
Short-container-title:International Health

Author:

Habib A.G.,Abubakar S.B.

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health,General Medicine,Health(social science)

Link

http://academic.oup.com/inthealth/article-pdf/3/1/50/1927365/3-1-50.pdf

Reference20 articles.

1. First clinical experience with a new ovine Fab Echis ocellatus snake bites antivenom in Nigeria. Randomized comparative trial with institute Pasteur Serum (IPSer) Africa antivenom;Meyer;Am J Trop Med Hyg,1997

2. Investigators of African Antivipmyn in Benin. Clinical trial of an F(ab’)2 polyvalent equine antivenom for African snake bites in Benin;Chippaux;Am J Trop Med Hyg,2007

3. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance;Visser;Trans R Soc Trop Med Hyg,2008

4. The importance of bites by the saw-scaled or carpet viper (Echis carinatus). Epidemiological studies in Nigeria and a review of the world literature;Warrell;Acta Trop,1976

5. Incidence and mortality of snakebite in savanna Nigeria;Pugh;Lancet,1980

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strikes and stripes of the Saw-scaled Viper in the Western Ghats-A case series;Toxicology Reports;2024-12

2. Anticoagulant activity in Australasian elapid snake venoms and neutralisation with antivenom and varespladib;Toxicon;2024-08

3. From fangs to antidotes: A scoping review on snakebite burden, species, and antivenoms in the Eastern Mediterranean Region;PLOS Neglected Tropical Diseases;2024-07-31

4. Consequences of geographical accessibility to post-exposure treatment for rabies and snakebite in Africa: a mini review;Frontiers in Health Services;2024-05-30

5. Considerations for the development of a field-based medical device for the administration of adjunctive therapies for snakebite envenoming;Toxicon: X;2023-12